Heranba Industries Limited (IN:HERANBA)
:HERANBA
Top Page
Heranba Industries Limited
(HERANBA)
Select Model
Select Model
Rating:49Neutral
Price Target:
₹156.00
▼(-35.92% Downside)
Action:ReiteratedDate:03/10/26
The score is held back primarily by operational and cash-flow weakness (declining margins and negative free cash flow) and a clearly bearish technical setup (price below key moving averages with weak momentum). A relatively steadier balance sheet provides some offset, while valuation support is limited due to the negative P/E and low dividend yield.
Positive Factors
Balance-sheet stability
A strong equity ratio and growing asset base reduce financial distress risk and provide a durable buffer against agricultural cyclical swings. This capacity supports ongoing operations, funding for registrations or capex, and longer-term strategic planning without immediate reliance on market financing.
Negative Factors
Weak cash generation
Persistent negative free cash flow undermines internal funding for capex, registrations and working capital, forcing reliance on external financing or equity. Over months, this constrains strategic flexibility, limits ability to deleverage, and increases vulnerability to interest-rate or liquidity stress.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet stability
A strong equity ratio and growing asset base reduce financial distress risk and provide a durable buffer against agricultural cyclical swings. This capacity supports ongoing operations, funding for registrations or capex, and longer-term strategic planning without immediate reliance on market financing.
Read all positive factors
Heranba Industries Limited (HERANBA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.26B
Dividend Yield0.39%
Average Volume (3M)3.99K
Price to Earnings (P/E)―
Beta (1Y)1.63
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees1,250
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)-5.81
Shares Outstanding40,013,466
10 Day Avg. Volume4,133
30 Day Avg. Volume3,992
Financial Highlights & Ratios
PEG Ratio-3.18
Price to Book (P/B)1.06
Price to Sales (P/S)0.63
P/FCF Ratio-5.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Heranba Industries Limited Business Overview & Revenue Model
Company Description
Heranba Industries Limited manufactures, markets, and sells a range of agrochemicals in India. The company provides intermediates, such as cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benza...
How the Company Makes Money
Heranba Industries primarily makes money by selling agrochemical formulations and, where applicable, technical (active ingredient) products used for crop protection. Revenue is generated through the domestic sale of branded and/or generic insectic...
Heranba Industries Limited Financial Statement Overview
Summary
Income Statement
55
Neutral
Balance Sheet
65
Positive
Cash Flow
45
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.53B | 14.17B | 12.49B | 13.11B | 14.35B | 12.02B |
| Gross Profit | 5.14B | 4.72B | 3.70B | 4.29B | 5.04B | 4.23B |
| EBITDA | 897.33M | 1.05B | 886.70M | 1.68B | 2.79B | 2.28B |
| Net Income | -472.10M | 30.70M | 348.90M | 1.04B | 1.89B | 1.54B |
Balance Sheet | ||||||
| Total Assets | 21.84B | 18.13B | 14.80B | 11.62B | 10.69B | 8.43B |
| Cash, Cash Equivalents and Short-Term Investments | 429.90M | 426.00M | 287.00M | 1.22B | 1.05B | 847.80M |
| Total Debt | 5.13B | 3.49B | 1.65B | 930.00M | 539.62M | 523.06M |
| Total Liabilities | 13.33B | 9.63B | 6.27B | 3.52B | 3.54B | 3.15B |
| Stockholders Equity | 8.42B | 8.41B | 8.43B | 8.10B | 7.14B | 5.28B |
Cash Flow | ||||||
| Free Cash Flow | -1.49B | -1.75B | -1.46B | 611.90M | 176.37M | 362.99M |
| Operating Cash Flow | -1.22B | 1.01B | 1.07B | 1.23B | 981.75M | 603.99M |
| Investing Cash Flow | -265.00M | -2.39B | -2.41B | -1.00B | -816.79M | -407.13M |
| Financing Cash Flow | 1.35B | 1.52B | 620.20M | -180.80M | -62.80M | 619.00M |
Heranba Industries Limited Technical Analysis
Negative
243.45
Price Trends
200.53
Negative
224.99
Negative
278.44
Negative
Market Momentum
-9.49
Negative
44.86
Neutral
41.93
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:HERANBA, the sentiment is Negative. The current price of 243.45 is above the 20-day moving average (MA) of 178.49, above the 50-day MA of 200.53, and below the 200-day MA of 278.44, indicating a bearish trend. The MACD of -9.49 indicates Negative momentum. The RSI at 44.86 is Neutral, neither overbought nor oversold. The STOCH value of 41.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:HERANBA.
Heranba Industries Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ₹82.60B | 13.57 | ― | 1.02% | 33.23% | 107.47% | |
64 Neutral | ₹44.56B | 33.24 | ― | 0.17% | 4.92% | 4.47% | |
63 Neutral | ₹46.95B | 700.00 | ― | 0.92% | 0.91% | 18.12% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹196.91B | 77.71 | ― | 0.26% | 8.69% | 12.26% | |
59 Neutral | ₹17.93B | 49.77 | ― | 0.71% | 6.86% | 15.64% | |
49 Neutral | ₹7.26B | -10.64 | ― | 0.39% | ― | ― |
* Basic Materials Sector Average
IN:HERANBA
Heranba Industries Limited
181.35
-45.95
-20.22%
IN:DHANUKA
Dhanuka Agritech Limited
977.75
-255.01
-20.69%
IN:INSECTICID
Insecticides (India) Limited
616.35
36.83
6.35%
IN:RALLIS
Rallis India Limited
241.45
40.92
20.41%
IN:SHARDACROP
Sharda Cropchem Ltd.
915.55
440.00
92.52%
IN:SUMICHEM
Sumitomo Chemical India Ltd.
394.50
-141.36
-26.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.